Welcome our new advisor, Tom McCarthy

Welcome Tom McCarthy! We are pleased to announce that Tom McCarthy has joined Greenlight Health Data Solutions as an Advisor. With over 40 years of experience across leading carriers and reinsurance companies, including 17 years at Swiss Re, Tom brings...

New FDA Policies Could Limit the Full Value of AI in Medicine 

The rapid advancement of artificial intelligence (AI) in medicine is paving the way for the potential development of artificial general intelligence (AGI), a revolutionary technology capable of understanding and solving complex medical problems with human-like proficiency. However, regulatory challenges, particularly...

We Need More Robust Post-Market Surveillance For Health Care AI

As AI and machine learning (ML) continue to transform health care, the importance of effective post-market surveillance mechanisms becomes clear. With nearly 1,000 AI-enabled medical devices approved as of 2024, ranging from predictive glucose monitors to AI-equipped smartwatches, there is...

Why data practices are key for pharma firms to engage patients

In a digital world, people are increasingly concerned about data privacy. The pharmaceutical industry is no exception. The growing importance of data privacy requires companies to prioritize effective patient consent and preference management. Personalized medicine, electronic health records, and an...